By Adam Bonislawski
Having recently inked deals with two contract research organizations, Japanese proteomics firm Proteomedix Frontiers is looking to apply its targeted mass spectrometry platform to drug discovery and development.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.
A BMJ study says that about half of former hematology-oncology regulators now work for industry.
Science should wish PhDs who leave academia well, a Nature editorial says.
New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.